Hydroxychloroquine in systemic lupus erythematosus (SLE).
about
Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013.The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus.Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus.Analysis of clinical risk factors in relapsed patients with class IV lupus nephritis.Therapeutic potential of CPI-613 for targeting tumorous mitochondrial energy metabolism and inhibiting autophagy in clear cell sarcoma.
P2860
Hydroxychloroquine in systemic lupus erythematosus (SLE).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hydroxychloroquine in systemic lupus erythematosus (SLE).
@en
Hydroxychloroquine in systemic lupus erythematosus
@nl
type
label
Hydroxychloroquine in systemic lupus erythematosus (SLE).
@en
Hydroxychloroquine in systemic lupus erythematosus
@nl
prefLabel
Hydroxychloroquine in systemic lupus erythematosus (SLE).
@en
Hydroxychloroquine in systemic lupus erythematosus
@nl
P2860
P1476
Hydroxychloroquine in systemic lupus erythematosus (SLE).
@en
P2093
C Ponticelli
P2860
P304
P356
10.1080/14740338.2017.1269168
P407
P577
2016-12-07T00:00:00Z